Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Critical Outcome Technologies Inc (COTQF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,121
  • Shares Outstanding, K 21,990
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,820 K
  • 36-Month Beta 1.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/04/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0332 +100.30%
on 12/28/18
0.0665 unch
on 01/16/19
+0.0303 (+83.70%)
since 12/12/18
3-Month
0.0332 +100.30%
on 12/28/18
0.0665 unch
on 01/16/19
-0.0108 (-13.97%)
since 10/16/18
52-Week
0.0100 +565.00%
on 10/02/18
1.4000 -95.25%
on 06/12/18
-0.9814 (-93.65%)
since 12/19/17

Most Recent Stories

More News
Cotinga Pharmaceuticals Doses First Patient With Combination Therapy in Phase 1b/2a Trial of COTI-2

Cotinga Pharmaceuticals Inc. (TSX Venture: COT) ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, today announced...

COTQF : 0.0665 (+30.39%)
COT.VN : 0.100 (unch)
Cotinga Pharmaceuticals Reports Fiscal 2019 Second Quarter Financial and Operating Results

Cotinga Pharmaceuticals Inc. (TSX Venture: COT; OTCQB: COTQF) ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer,...

COTQF : 0.0665 (+30.39%)
COT.VN : 0.100 (unch)
Cotinga Pharmaceuticals Announces Presentation on COTI-2 at the 2018 American Society of Clinical Oncology Annual Meeting

Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer,...

COTQF : 0.0665 (+30.39%)
COT.VN : 0.100 (unch)
Cotinga Pharmaceuticals Closes $2.0M Private Placement

Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer,...

COTQF : 0.0665 (+30.39%)
COT.VN : 0.100 (unch)
Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer,...

COTQF : 0.0665 (+30.39%)
COT.VN : 0.100 (unch)
Cotinga Pharmaceuticals Announces Presentation on COTI-2 at the American Association for Cancer Research (AACR) Annual Meeting 2018

Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer,...

COTQF : 0.0665 (+30.39%)
COT.VN : 0.100 (unch)
Cotinga Pharmaceuticals Provides Update on COTI-2 Clinical Programs

Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) ("Cotinga" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer,...

COTQF : 0.0665 (+30.39%)
COT.VN : 0.100 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade COTQF with:

Key Turning Points

2nd Resistance Point 0.0665
1st Resistance Point 0.0665
Last Price 0.0665
1st Support Level 0.0665
2nd Support Level 0.0665

See More

52-Week High 1.4000
Fibonacci 61.8% 0.8690
Fibonacci 50% 0.7050
Fibonacci 38.2% 0.5410
Last Price 0.0665
52-Week Low 0.0100

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar